Home Top News Founder, executives of pharmaceutical company set to be sentenced in scheme of...

Founder, executives of pharmaceutical company set to be sentenced in scheme of over-prescribing painkillers

Founder, executives of pharmaceutical company set to be sentenced in scheme of over-prescribing painkillers


Dear Reader,

By now you’ve heard big promises about 5G.

5G will make you rich… 5G will change your life… 5G will usher in the new Industrial Revolution.

You’ve seen the Super Bowl commercials. And every one touting the next big 5G stock.

I won’t try to top any of them.

But instead, I’ll come clean and reveal the hard truth the pundits will never say…

And this is it: All the hype about 5G is useless.

Without the technology of this one tiny company, there will be no 5G rollout across America.

That’s why Facebook, Lockheed Martin, L3, Sprint, T-Mobile, China Satcom, and dozens of networks are banging on this company’s door.

And for the first time, this tiny $8 company is about to roll out this long-awaited technology.

To be one of the first to get in on this big stock market opportunity…

Check out this research briefing now.


E.B. Tucker,

Senior Analyst, Strategic Investor

FILE – A protester gathers containers that look like OxyContin bottles at an anti-opioid demonstration in front of the U.S. Department of Health and Human Services headquarters in Washington, D.C. (AP Photo/Patrick Semansky)

OAN Newsroom
UPDATED 11:20 AM PT — Monday, January 13, 2020

The justice system is looking to crackdown on perpetrators of the opioid crisis as a federal court looks to set a precedent with high level executives of a pharmaceutical company. Recent reports confirmed the sentencing of seven top former employees, including the founder of Insys Therapeutics, who are set to appear in front of a federal judge in Boston, Massachusetts.

The case surrounding Insys founder John Kapoor and his employees stem from their scheme to over-prescribe their opioid product, which has affected nearly 400,000 lives over two decades.

“People who are desperate for pain relief because they’ve suffered terrible pain injuries, and to see them being taken advantage of like this is sickening,” said attorney Michael Rainboth.

The company bribed doctors to over-prescribe their fentanyl-based oral spray Subsys to cancer patients seeking to ease their pain. Insys also misled insurance companies to pay for the drug, which costs $19,000 a month.

FILE – In this Jan. 30, 2019, file photo, Insys Therapeutics founder John Kapoor leaves federal court in Boston. (AP Photo/Steven Senne, File)

Former employee Patty Nixon blew the whistle on the company’s practices,  which resulted in an extensive legal battle causing Insys to file for bankruptcy and settle $225 million with the Department of Justice.

Once the convictions of executives began, Nixon expressed hope her actions would cause longstanding changes to the industry.

“The pharmaceutical companies have been able to get away with criminal activity for a very long time,” she stated. “I think this decision, today, will change the entire industry as it should…it’s not okay to put patients’ lives at risk for profit.”

While the defendants can face up to 20 years in prison, prosecutors aren’t seeking a maximum penalty. They are looking to sentence Kapoor to 15 years, while arguing that he is the leader of the bribery scheme. The other defendants are being pushed to serve anywhere from five to 11 years behind bars. Sentencing hearings begin Monday, January 13, 2020.

RELATED: MLB Removes Marijuana From ‘Drugs Of Abuse,’ To Test Major League Players For Opioids

View original Post


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.